C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: Inhibitory effect of fluvastatin

Life Sciences

Volumn 78, Issue 9, 2006, Pages 1021-1028

  Abe, Naoki ^a   Osanai, Tomohiro ^a   Fujiwara, Takayuki ^a   Kameda, Kunihiko ^a   Matsunaga, Toshiro ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

C reactive protein; Extracellular matrix metalloproteinase inducer; Fluvastatin; Matrix metalloproteinase 9

Indexed keywords

C REACTIVE PROTEIN; CD147 ANTIGEN; DIPHENYLIODONIUM SALT; FLUINDOSTATIN; GELATINASE B; PROSTAGLANDIN F2 ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME INHIBITION; GENE EXPRESSION; IN VITRO STUDY; MACROPHAGE ACTIVATION; NONHUMAN; PERITONEUM MACROPHAGE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ANIMALS; ANTIGENS, CD147; ANTIOXIDANTS; C-REACTIVE PROTEIN; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FATTY ACIDS, MONOUNSATURATED; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

ANIMALIA;

EID: 30944460859     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.06.015     Document Type: Article

References (29)

1. M. Aikawa, E. Rabkin, Y. Okada, S.J. Voglic, S.K. Clinton, C.E. Brinckerhoff, G.K. Sukhova, and P. Libby Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization Circulation 97 24 1998 2433 2444
2. S. Bellosta, D. Via, M. Canavesi, P. Pfister, R. Fumagalli, R. Paoletti, and F. Bernini HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages Arteriosclerosis, Thrombosis, and Vascular Biology 18 11 1998 1671 1678
3. T.M. Bocan, B.R. Krause, W.S. Rosebury, S.B. Mueller, X. Lu, C. Dagle, T. Major, C. Lathia, and H. Lee The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits Arteriosclerosis, Thrombosis, and Vascular Biology 20 1 2000 70 79
4. A.P. Burke, R.P. Tracy, F. Kolodgie, G.T. Malcom, A. Zieske, R. Kutys, J. Pestaner, J. Smialek, and R. Virmani Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies Circulation 105 17 2002 2019 2023
5. J. Cermak, N.S. Key, R.R. Bach, J. Balla, H.S. Jacob, and G.M. Vercellotti C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor Blood 82 2 1993 513 520
6. E. Falk, P.K. Shah, and V. Fuster Coronary plaque disruption Circulation 92 3 1995 657 671
7. Y. Fukumoto, P. Libby, E. Rabkin, C.C. Hill, M. Enomoto, Y. Hirouchi, M. Shiomi, and M. Aikawa Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits Circulation 103 7 2001 993 999
8. Z.S. Galis, G.K. Sukhova, R. Kranzhofer, S. Clark, and P. Libby Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases Proceedings of the National Academy of Sciences of the United States of America 92 2 1995 402 406
9. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 9326 2002 7 22
10. D.E. Kleiner, and W.G. Stetler-Stevenson Quantitative zymography: detection of pictogram quantities of gelatinases Analytical Biochemistry 218 2 1994 325 329
11. L. Liang, T. Major, and T. Bocan Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN) Gene 282 1-2 2002 75 86
12. T.C. Major, L. Liang, X. Lu, W. Rosebury, and T.M. Bocan Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma Arteriosclerosis, Thrombosis, and Vascular Biology 22 7 2002 1200 1207
13. S.T. Nikkari, K.D. O'Brien, M. Ferguson, T. Hatsukami, H.G. Welgus, C.E. Alpers, and A.W. Clowes Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis Circulation 92 6 1995 1393 1398
14. V. Pasceri, J.S. Cheng, J.T. Willerson, and E.T. Yeh Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs Circulation 103 16 2001 2531 2534
15. S. Rajagopalan, X.P. Meng, S. Ramasamy, D.G. Harrison, and Z.S. Galis Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability Journal of Clinical Investigation 98 11 1996 2572 2579
16. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women New England Journal of Medicine 342 12 2000 836 843
17. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 6423 1993 801 809
18. S. Sigurbjornsson, T. Kjartansdottir, M. Johannsson, J. Kristinsson, and G. Sigurdsson A pharmacokinetic evaluation of pravastatin in middle-aged and elderly volunteers European Journal of Drug Metabolism and Pharmacokinetics 23 1 1998 13 18
19. J.W. Smit, H.J. Wijnne, F. Schobben, A. Sitsen, T.W. deBruin, and D.W. Erkelens Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastatin American Journal of Cardiology 76 2 1995 89A 96A
20. K. Suzumura, K. Tanaka, M. Yasuhara, and H. Narita Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein Biological & Pharmaceutical Bulletin 23 7 2000 873 878
21. J. Torzewski, M. Torzewski, D.E. Bowyer, M. Frohlich, W. Koenig, and J. Waltenberger C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries Arteriosclerosis, Thrombosis, and Vascular Biology 18 9 1998 1386 1392
22. J.J. van, den, Oord, L. Paemen, G. Opdenakker, and C. de, Wolf-Peeters Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin American Journal of Pathology 151 3 1997 665 670
23. S.K. Venugopal, S. Devaraj, I. Yuhanna, P. Shaul, and I. Jialal Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 106 12 2002 1439 1441
24. S. Verma, S.H. Li, M.V. Badiwala, R.D. Weisel, P.W. Fedak, R.K. Li, B. Dhillon, and D.A. Mickle Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein Circulation 105 16 2002 1890 1896
25. C.H. Wang, S.H. Li, R.D. Weisel, P.W. Fedak, A.S. Dumont, P. Szmitko, R.K. Li, D.A. Mickle, and S. Verma C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle Circulation 107 15 2003 1783 1790
26. S. Wassmann, U. Laufs, K. Muller, C. Konkol, K. Ahlbory, A.T. Baumer, W. Linz, M. Bohm, and G. Nickenig Cellular antioxidant effects of atorvastatin in vitro and in vivo Arteriosclerosis, Thrombosis, and Vascular Biology 22 2 2002 300 305
27. T.N. Williams, C.X. Zhang, B.A. Game, L. He, and Y. Huang C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization Arteriosclerosis, Thrombosis, and Vascular Biology 24 1 2004 61 66
28. J.M. Yang, Z. Xu, H. Wu, H. Zhu, X. Wu, and W.N. Hait Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells Molecular Cancer Research 1 6 2003 420 427
29. F.L. Zhang, and P.J. Casey Protein prenylation: molecular mechanisms and functional consequences Annual Reviews of Biochemical 65 1996 241 269